BioVie Inc. Warrant
BIVIW
Last
$0.29
Day
+3.5%
1y
-22.9%
5y
-22.9%
52w
-65.8%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.30
EMA 50
0.31
EMA 200
0.33
20d high
-54.2%
5y high
-65.8%
5y range
21th
Positions held
Your positionsBIVIW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-18
Hold
avoid
Signal
Strong Sell
Target
$0.35
Stop
$0.20
Stop distance
31.0%
Target vs last
+20.7%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.20 | Beta | 0.73 | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -1.5% | ROA | -79.1% | Debt / equity | 0.03 |
| Current ratio | 3.59 | Free cash flow | -$11.12M | Analyst recommendation | none | Mean target | — |
| 52w high | $0.30 | 52w low | $0.27 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$5.6M | -$5.3M | -$6.1M | -$5.1M | -$3.5M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$5.7M | -$5.4M | -$6.3M | -$5.3M | -$3.7M | — |
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$22.1M | -$17.5M | -$32.1M | -$50.3M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$22.7M | -$18.1M | -$32.2M | -$45.1M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsBIVIW · daily-6.9% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin